The abstract is read at the publisher; the summary is JClub's.
In induced pluripotent stem cell–derived heterogeneous differentiating cultures from 49 individuals, ALK inhibitor treatment yields 2,137 response eQTLs across 21 cell types.
- Why it matters: Patient-to-patient differences in ALK inhibitor adverse events are hard to explain because treated cohorts are small and affected tissues span many cell types.
- What they did: The study generated heterogeneous differentiating cultures from 49 individuals, exposed them for 24 hours to five ALK inhibitors, and used single-cell RNA sequencing to map 4,371 eQTLs and 2,137 response eQTLs.
- The result: Cell-type-specific and shared transcriptional effects were observed, and genotype-linked regulatory variants that change with drug exposure nominate candidates for future studies of ALK inhibitor toxicity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.